CollPlant Biotechnologies
CLGN
CLGN
21 hedge funds and large institutions have $29.5M invested in CollPlant Biotechnologies in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $33.1M → $29.5M (-$3.62M)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
88% less call options, than puts
Call options by funds: $3K | Put options by funds: $26K
Holders
21
Holding in Top 10
1
Calls
$3K
Puts
$26K
Top Buyers
| 1 | +$731K | |
| 2 | +$403K | |
| 3 | +$301K | |
| 4 |
LPL Financial
San Diego,
California
|
+$242K |
| 5 |
HF
HRT Financial
New York
|
+$221K |
Top Sellers
| 1 | -$3.08M | |
| 2 | -$1.1M | |
| 3 | -$423K | |
| 4 |
Renaissance Technologies
New York
|
-$169K |
| 5 |
ACM
ACT Capital Management
Wayne,
Pennsylvania
|
-$127K |